Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms
- PMID: 22851508
- DOI: 10.1002/stem.1182
Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms
Abstract
Embryonic NANOG (NANOG1) is considered as an important regulator of pluripotency while NANOGP8 (NANOG-pseudogene) plays a role in tumorigenesis. Herein, we show NANOG is expressed from both NANOG1 and NANOGP8 in human colorectal cancers (CRC). Enforced NANOG1-expression increases clonogenic potential and tumor formation in xenograft models, although it is expressed only in a small subpopulation of tumor cells and is colocalized with endogenous nuclear β-catenin(High) . Moreover, single NANOG1-CRCs form spherical aggregates, similar to the embryoid body of embryonic stem cells (ESCs), and express higher levels of stem-like Wnt-associated target genes. Furthermore, we show that NANOG1-expression is positively regulated by c-JUN and β-catenin/TCF4. Ectopic expression of c-Jun in murine Apc(Min/+) -ESCs results in the development of larger xenograft tumors with higher cell density compared to controls. Chromatin immunoprecipitation assays demonstrate that c-JUN binds to the NANOG1-promoter via the octamer M1 DNA element. Collectively, our data suggest that β-Catenin/TCF4 and c-JUN together drive a subpopulation of CRC tumor cells that adopt a stem-like phenotype via the NANOG1-promoter.
Copyright © 2012 AlphaMed Press.
Similar articles
-
β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19204-9. doi: 10.1073/pnas.1108977108. Epub 2011 Nov 11. Proc Natl Acad Sci U S A. 2011. PMID: 22080605 Free PMC article.
-
A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.Cell Cycle. 2015;14(3):323-32. doi: 10.4161/15384101.2014.980643. Cell Cycle. 2015. PMID: 25659031 Free PMC article.
-
ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15. Gastroenterology. 2014. PMID: 24846398
-
[In situ analyses of molecular mechanisms of colorectal carcinogenesis].Pathologe. 2013 Nov;34 Suppl 2:269-73. doi: 10.1007/s00292-013-1821-y. Pathologe. 2013. PMID: 24196627 Review. German.
-
Regulation of NANOG in cancer cells.Mol Carcinog. 2015 Sep;54(9):679-87. doi: 10.1002/mc.22340. Epub 2015 May 27. Mol Carcinog. 2015. PMID: 26013997 Free PMC article. Review.
Cited by
-
Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.Stem Cells. 2015 Aug;33(8):2381-90. doi: 10.1002/stem.2007. Epub 2015 May 13. Stem Cells. 2015. PMID: 25821200 Free PMC article. Review.
-
Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors.Cancers (Basel). 2022 Feb 25;14(5):1195. doi: 10.3390/cancers14051195. Cancers (Basel). 2022. PMID: 35267511 Free PMC article.
-
Inhibition of NANOG/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics.Clin Cancer Res. 2014 Nov 1;20(21):5446-55. doi: 10.1158/1078-0432.CCR-14-1134. Epub 2014 Sep 10. Clin Cancer Res. 2014. PMID: 25208882 Free PMC article.
-
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.Cell Cycle. 2013 Aug 1;12(15):2395-408. doi: 10.4161/cc.25402. Epub 2013 Jun 26. Cell Cycle. 2013. PMID: 23839044 Free PMC article.
-
Common stemness regulators of embryonic and cancer stem cells.World J Stem Cells. 2015 Oct 26;7(9):1150-84. doi: 10.4252/wjsc.v7.i9.1150. World J Stem Cells. 2015. PMID: 26516408 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
